Provided herein are pharmaceutical compositions, which comprise a 1,2,4-oxadiazole benzoic acid or a pharmaceutically acceptable salt thereof. Further provided herein are certain pharmaceutically acceptable salts of a 1,2,4-oxadiazole benzoic acid and methods for making the same. Further provided herein are methods of treating or preventing a disease associated with a nonsense mutation or a premature stop codon, comprising administering such pharmaceutical compositions or pharmaceutically acceptable salts to a patient having a disease associated with a nonsense mutation or a premature stop codon.本文提供醫藥組合物，其包含1,2,4-二唑苯甲酸或其醫藥學上可接受之鹽。本文進一步提供1,2,4-二唑苯甲酸之某些醫藥學上可接受之鹽及其製造方法。本文進一步提供治療或預防與無意義突變或過早終止密碼子相關之疾病之方法，其包含向患有與無意義突變或過早終止密碼子相關之疾病之患者投與該等醫藥組合物或醫藥學上可接受之鹽。
